Fajgenbaum Jonas
Known title: DirectorCIK: 0001376855
Fajgenbaum Jonas's purchase track record
Fajgenbaum Jonas has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/10/2022 | WW | $125K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| WW | ▲ Buy | Grant | 835 | $0 | 5/9/2023 | View on chart |
| WW | ▲ Buy | Grant | 2,053 | $0 | 4/3/2023 | View on chart |
| WW | ▲ Buy | Grant | 5,067 | $0 | 1/2/2023 | View on chart |
| WW | ▲ Buy | Open Market | 29,250 | $125K | 11/10/2022 | View on chart |
| WW | ▲ Buy | Grant | 4,595 | $0 | 10/3/2022 | View on chart |
| WW | ▲ Buy | Grant | 2,745 | $0 | 7/4/2022 | View on chart |
| WW | ▲ Buy | Grant | 1,797 | $0 | 4/4/2022 | View on chart |
| WW | ▲ Buy | Grant | 1,179 | $19K | 1/3/2022 | View on chart |
| WW | ▲ Buy | Grant | 998 | $19K | 10/4/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
WW International Reports Momentum in GLP-1 Care and Cash Flow
WW International is highlighting a potential cash flow turnaround driven by growing momentum in its GLP-1 care services. This development is relevant to the company's broader strategy as it seeks to adapt to changes in the weight management market. The stock currently trades near its support level, with analysts maintaining a higher average price target than the current market price.
WW International Reports Momentum in GLP-1 Care and Cash Flow. WW International is highlighting a potential cash flow turnaround driven by growing momentum in its GLP-1 care services. This development is relevant to the company's broader strategy as it seeks to adapt to changes in the weight management market. The stock currently trades near its support level, with analysts maintaining a higher average price target than the current market price.